"I'm Going to Stop Myself Before Someone Stops Me": Complicating Narratives of Volitional Substance Use Treatment
- PMID: 33869574
- PMCID: PMC8022605
- DOI: 10.3389/fsoc.2021.619677
"I'm Going to Stop Myself Before Someone Stops Me": Complicating Narratives of Volitional Substance Use Treatment
Abstract
Background: Often people assume that entry into drug treatment is a voluntary action for persons who use drugs (PWUD). This narrative informs the organizational and regulatory structure of most treatment programs and consequently affects patients' ability to exert agency over their own treatment. Yet, this view ignores the complex interplay between individual and structural factors in peoples' decision-making processes, particularly among people who use drugs who are stigmatized and criminalized. Treatment programs that assume voluntary entry may lack appropriate services for the populations of treatment seekers that they serve. Methods: This paper uses semi-structured interviews with 42 participants in Opioid Substitution Treatment (OST) (including patients, clinic doctors and staff, and advocates) informed by one of the author's own lived experience in OST, to examine patients' treatment decisions, and in particular, if and how, the structural context of drugs' illegality/criminalization affected their willingness to pursue treatment. A Critical Discourse Analysis was used to identify key themes. Results: Interview data demonstrates that most people who use drugs enter treatment under constrained conditions related to drugs' illegality. Themes that emerged included: 1. A feeling of limited choices due to drugs' illegality; 2. Peer and family pressure; 3. Fear of losing children; and 4. Internalized stigma (i.e. feeling they are dirty or bad for using). Conclusion: Narratives that frame PWUD's treatment decisions as volitional provide political cover to policies that criminalize PWUD by obscuring their effect on PWUD's treatment decisions. Treatment models, particularly those that serve highly criminalized populations, should be re-conceptualized outside of normative narratives of individual choice, and be broadened to understand how larger structures constrain choices. By looking at macro-level factors, including the interplay of criminalization and drug treatment, programs can begin to understand the complexity of PWUD motivations to enter drug treatment. Recognizing the role of the War on Drugs as a force of oppression for people who use drugs, and that their treatment decisions are made within that setting, may enable people in treatment, and providers, to develop more productive ways of interacting with one another. Additionally, this may lead to better retention in treatment programs.
Keywords: criminalization; methadone maintenance treatment; patient agency; stigmatized populations; treatment decisions.
Copyright © 2021 Frank and Walters.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
Medical provider stigma experienced by people who use drugs (MPS-PWUD): Development and validation of a scale among people who currently inject drugs in New York City.Drug Alcohol Depend. 2021 Apr 1;221:108589. doi: 10.1016/j.drugalcdep.2021.108589. Epub 2021 Feb 13. Drug Alcohol Depend. 2021. PMID: 33621804 Free PMC article.
-
'It's too much, I'm getting really tired of it': Overdose response and structural vulnerabilities among harm reduction workers in community settings.Int J Drug Policy. 2019 Dec;74:127-135. doi: 10.1016/j.drugpo.2019.09.012. Epub 2019 Oct 4. Int J Drug Policy. 2019. PMID: 31590088
-
"I Was Not Sick and I Didn't Need to Recover": Methadone Maintenance Treatment (MMT) as a Refuge from Criminalization.Subst Use Misuse. 2018 Jan 28;53(2):311-322. doi: 10.1080/10826084.2017.1310247. Epub 2017 Jul 13. Subst Use Misuse. 2018. PMID: 28704148 Free PMC article.
-
Overdose education and naloxone distribution program design informed by people who use drugs and naloxone distributors.Prev Med Rep. 2023 Aug 19;35:102374. doi: 10.1016/j.pmedr.2023.102374. eCollection 2023 Oct. Prev Med Rep. 2023. PMID: 37680861 Free PMC article.
-
Beyond harm-producing versus harm-reducing: A qualitative meta-synthesis of people who use drugs' perspectives of and experiences with the extramedical use and diversion of buprenorphine.J Subst Abuse Treat. 2022 Apr;135:108651. doi: 10.1016/j.jsat.2021.108651. Epub 2021 Oct 28. J Subst Abuse Treat. 2022. PMID: 34728134 Review.
Cited by
-
The Discursive Configuration of the Therapeutic Community for Substance Users: Positioning and Ethnopsychological Processes Concerning Entry.Behav Sci (Basel). 2024 Oct 15;14(10):951. doi: 10.3390/bs14100951. Behav Sci (Basel). 2024. PMID: 39457823 Free PMC article.
-
Lessons from the First Wave of COVID-19 for Improved Medications for Opioid Use Disorder (MOUD) Treatment: Benefits of Easier Access, Extended Take Homes, and New Delivery Modalities.Subst Use Misuse. 2022;57(7):1144-1153. doi: 10.1080/10826084.2022.2064509. Epub 2022 Apr 21. Subst Use Misuse. 2022. PMID: 35443862 Free PMC article.
-
"As safe as possible": a qualitative study of opioid withdrawal and risk behavior among people who use illegal opioids.Harm Reduct J. 2023 Oct 27;20(1):158. doi: 10.1186/s12954-023-00893-9. Harm Reduct J. 2023. PMID: 37891630 Free PMC article.
-
Community-, network-, and individual-level predictors of uptake of medication for opioid use disorder among young people who inject drugs and their networks: A multilevel analysis.Drug Alcohol Depend. 2023 Mar 1;244:109782. doi: 10.1016/j.drugalcdep.2023.109782. Epub 2023 Jan 20. Drug Alcohol Depend. 2023. PMID: 36738633 Free PMC article.
-
"It's like 'liquid handcuffs": The effects of take-home dosing policies on Methadone Maintenance Treatment (MMT) patients' lives.Harm Reduct J. 2021 Aug 14;18(1):88. doi: 10.1186/s12954-021-00535-y. Harm Reduct J. 2021. PMID: 34391436 Free PMC article.
References
-
- Alderks C. (2017). Trends in the Use of Methadone/Buprenorphine, and extended-release naltrexone at substance abuse treatment facilities: 2003-1015. Rockville, MD: SAMHSA. - PubMed
-
- Allison J. C., Ross A. (2014). The effectiveness of methadone maintenance treatment: patients, programs, services, and outcome. Berlin, Germany: Springer Science and Business Media.
-
- Bloom L. R. (1998). Under the sign of hope: feminist methodology and narrative interpretation. Albany, NY: SUNY Press.
-
- Campbell N. D. (2011). From “magic bullets” to medical maintenance. Suzanne fraser is associate professor in the centre for women’s studies and gender research, school of political and social inquiry. Melbourne, Australia: Faculty of Arts, Monash University. She also holds a research appointment with the National Drug Research Institute at Curtin University, 122.
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials